These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3786837

  • 21. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
    Malmström RE, Lundberg JM.
    Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
    [Abstract] [Full Text] [Related]

  • 22. Sympathetic thyroidal vasoconstriction is not blocked by a neuropeptide Y antagonist or antiserum.
    Dey M, Michalkiewicz M, Huffman L, Hedge GA.
    Peptides; 1993 Nov; 14(6):1179-86. PubMed ID: 8134299
    [Abstract] [Full Text] [Related]

  • 23. Intracerebroventricular administration of NPY increases sympathetic tone selectively in vascular beds.
    Hu Y, Dunbar JC.
    Brain Res Bull; 1997 Nov; 44(1):97-103. PubMed ID: 9288836
    [Abstract] [Full Text] [Related]

  • 24. No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation.
    Pernow J, Modin A, Lundberg JM.
    Eur J Pharmacol; 1992 Nov 03; 222(1):171-4. PubMed ID: 1468494
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Nonadrenergic sympathetic vascular control of the human forearm in hypertension: possible involvement of neuropeptide Y.
    Kahan T, Taddei S, Pedrinelli R, Hjemdahl P, Salvetti A.
    J Cardiovasc Pharmacol; 1992 Apr 03; 19(4):587-92. PubMed ID: 1380602
    [Abstract] [Full Text] [Related]

  • 30. Hemodynamic and sympathetic effects of spinal administration of neuropeptide Y in rats.
    Chen XL, Knuepfer MM, Westfall TC.
    Am J Physiol; 1990 Dec 03; 259(6 Pt 2):H1674-80. PubMed ID: 2260694
    [Abstract] [Full Text] [Related]

  • 31. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
    Schwieler JH, Hjemdahl P.
    J Cardiovasc Pharmacol; 1993 Mar 03; 21(3):347-52. PubMed ID: 7681493
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacology of H 394/84, a dihydropyridine neuropeptide Y Y(1) receptor antagonist, in vivo.
    Malmström RE, Balmér KC, Weilitz J, Nordlander M, Sjölander M.
    Eur J Pharmacol; 2001 Apr 20; 418(1-2):95-104. PubMed ID: 11334870
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Neuropeptide Y and control of vascular resistance in skeletal muscle.
    Revington M, McCloskey DI.
    Regul Pept; 1988 Dec 20; 23(3):331-42. PubMed ID: 3238054
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.